Empiric concomitant coverage of MRSA and multidrug-resistant organisms is not necessary for most patients with sepsis.
Discover Magazine on MSN
New Antibiotic Could be 100 Times More Potent and Has Potential to Save Countless Lives
Learn how chemists were studying a known antibiotic when they discovered a molecule 100 times more potent at defeating ...
Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a ...
Explore the list of 280 hospitals with the lowest MRSA rates based on CMS data from October 2023 to September 2024.
Scientists have found a new antibiotic that could be over 100 times more effective in fighting ‘superbugs’ than existing ...
During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical ...
ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School ...
Leslie Ash describes how she learnt to walk again after suffering from a hospital superbug and the moment she realised her ...
In the United States, Black patients had methicillin-resistant S aureus (MRSA) rates that were two to three times higher than ...
Phages are particularly advantageous anti-infectives as they are novel therapeutics, can target antibiotic-resistant bacteria ...
Revium Rx (formerly Revium Recovery Inc. (OTC: RVRC), a biopharmaceutical company developing advanced lipid-based therapeutics for infectious and oncologic diseases, today announced significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results